Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?

Ann Surg. 2016 Feb;263(2):e28-9. doi: 10.1097/SLA.0000000000001035.

Authors

Guusje Vugts¹, Grard A P Nieuwenhuijzen, Adriana J G Maaskant-Braat, Robert J Schipper, Marjolein L Smidt

Affiliation

¹ Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

PMID: 25405555
DOI: 10.1097/SLA.0000000000001035

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / diagnostic imaging*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / diagnostic imaging*
Female
Humans
Iodine Radioisotopes*
Lymph Node Excision*
Lymph Nodes / diagnostic imaging*
Radionuclide Imaging
Radiopharmaceuticals*

Substances

Iodine Radioisotopes
Radiopharmaceuticals